The FDA wrapped up 2024 with 50 new drug approvals, clearing a wave of long-awaited treatments. Meanwhile, Transcarent will ...

The US Food and Drug Administration approved 50 new molecular entities in 2024 —just five fewer than it did in 2023. Last ...

The U.S. Food and Drug Administration said on Friday that it has approved an injectable version of Bristol Myers Squibb's ...

GoodRx released a list of 19 of the most influential drugs and vaccines approved by the FDA in 2024 to treat a variety of ...

Stay updated on the latest potential FDA drug approvals in 2025, including an expanded label for Ozempic and new, nonopioid painkillers.

The FDA approved a wide range of therapies in 2024, including many new molecular entities and biological products.

The agency’s main drug review office cleared 50 novel medicines last year, short of 2018’s record total but on the higher end ...

On January 6, the FDA announced the availability of draft guidance on accelerated approval for drugs and biological products, and consideration ...

Researchers from Canada reviewed the results of 26 trials to determine which of the weight loss jabs are the most effective ...

AscellaHealth, a global partner delivering customizable solutions to support the specialty pharmaceutical industry, today ...

Medicare recipients who take expensive prescriptions will get a break this year with a $2,000 cap on drug costs.